Completed PHASE2 INTERVENTIONAL 2-arm NCT01065935

Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

Sponsor: Alnylam Pharmaceuticals

Conditions Respiratory Syncytial Virus Infections

Interventions ALN-RSV01 Normal Saline

Updated 9 times since 2017 Last updated: Jan 31, 2018 Started: Feb 28, 2010 Primary completion: Apr 30, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01065935, this PHASE2 trial focuses on Respiratory Syncytial Virus Infections and remains completed. Sponsored by Alnylam Pharmaceuticals, it has been updated 9 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Mar 2018 — Jun 2018 [monthly]

Completed PHASE2
Feb 2017 — Mar 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alnylam Pharmaceuticals

Data source: Alnylam Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Ann Arbor, United States , Atlanta, United States , Berlin, Germany , Boston, United States , Chicago, United States , Cleveland, United States , Dallas, United States , Darlinghurst, Australia , Denver, United States and 21 more locations